Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9)
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2005
|
| _version_ | 1826268822865182720 |
|---|---|
| author | Bottazzo, G Bosi, E Cull, C Bonifacio, E Locatelli, M Zimmet, P Mackay, I Holman, R |
| author_facet | Bottazzo, G Bosi, E Cull, C Bonifacio, E Locatelli, M Zimmet, P Mackay, I Holman, R |
| author_sort | Bottazzo, G |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T21:15:30Z |
| format | Journal article |
| id | oxford-uuid:3fa99722-5385-4824-b6ea-093962d2f6cb |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:15:30Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:3fa99722-5385-4824-b6ea-093962d2f6cb2022-03-26T14:33:21ZErratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3fa99722-5385-4824-b6ea-093962d2f6cbEnglishSymplectic Elements at Oxford2005Bottazzo, GBosi, ECull, CBonifacio, ELocatelli, MZimmet, PMackay, IHolman, R |
| spellingShingle | Bottazzo, G Bosi, E Cull, C Bonifacio, E Locatelli, M Zimmet, P Mackay, I Holman, R Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9) |
| title | Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9) |
| title_full | Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9) |
| title_fullStr | Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9) |
| title_full_unstemmed | Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9) |
| title_short | Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: http://dx.doi.org/10.1007/s00125-005-1691-9) |
| title_sort | erratum ia 2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes ukpds 71 diabetologia 2005 48 703 708 doi http dx doi org 10 1007 s00125 005 1691 9 |
| work_keys_str_mv | AT bottazzog erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT bosie erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT cullc erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT bonifacioe erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT locatellim erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT zimmetp erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT mackayi erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 AT holmanr erratumia2antibodyprevalenceandriskassessmentofearlyinsulinrequirementinsubjectspresentingwithtype2diabetesukpds71diabetologia200548703708doihttpdxdoiorg101007s0012500516919 |